Delivery Order SPE2DB20D2104-SPE2DB22FQ68C
- Not listed
- This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60s, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is a subsidiary of Cencora, Inc. The contract has a ceiling value of $12,050.28 and was awarded on November 8, 2021, with a completion date of November 9, 2021. The contract is a delivery order under a larger Indefinite...
- This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $10,800.64. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support...
- This federal contract award is for the delivery of Trelegy Ellipta 200-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $11,307.48 and an ultimate completion date of February 10, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
- This federal contract award is for the delivery of Trelegy Ellipta medication (100-62.5-25 60 doses) to the Defense Logistics Agency (DLA). The $7,205.83 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of September 9, 2021 and was awarded on September 8, 2021. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the...
- This federal contract award is for the delivery of pharmaceutical products, specifically Trelegy Ellipta 100-62.5-25 60S, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $2,874.69. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC is valued at up to...
- This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) on a firm-fixed-price basis. The contract has a ceiling value of $7,210.71 and an ultimate completion date of April 21, 2022. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider for federal agencies. Amerisourcebergen has an extensive Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $11,783.89 and an ultimate completion date of November 16, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA...
- This federal contract award is for the supply of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $10,102.50 and an ultimate completion date of August 15, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor to the U.S. federal government. This order is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S medication to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a pharmaceutical distribution and healthcare solutions provider. The contract has a ceiling value of $10,088.39 and was issued as a delivery order. It does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also...
- This federal contract award is for the pharmaceutical product Trelegy Ellipta, which is being procured by the Defense Logistics Agency (DLA) through a delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,210.02 and a completion date of July 27, 2023. It is a firm fixed-price contract, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FQ68CDelivery Order
This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60s medication to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $13,649.99 and was awarded on October 8, 2021 with an ultimate completion date of October 12, 2021. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award was made through full and open competition without any set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 10/8/21 |